Literature DB >> 18823228

The role of serotonin in nonnormative risky choice: the effects of tryptophan supplements on the "reflection effect" in healthy adult volunteers.

Susannah E Murphy1, Carlo Longhitano, Rachael E Ayres, Philip J Cowen, Catherine J Harmer, Robert D Rogers.   

Abstract

Risky decision-making involves weighing good and bad outcomes against their probabilities in order to determine the relative values of candidate actions. Although human decision-making sometimes conforms to rational models of how this weighting is achieved, irrational (or nonnormative) patterns of risky choice, including shifts between risk-averse and risk-seeking choices involving equivalent-value gambles (the "reflection effect"), are frequently observed. In the present experiment, we investigated the role of serotonin in decision-making under conditions of uncertainty. Fifteen healthy adult volunteers received a treatment of 3 g per day of the serotonin precursor, tryptophan, in the form of dietary supplements over a 14-day period, whereas 15 age- and IQ-matched control volunteers received a matched placebo substance. At test, all participants completed a risky decision-making task involving a series of choices between two simultaneously presented gambles, differing in the magnitude of their possible gains, the magnitude of their possible losses, and the probabilities with which these outcomes were delivered. Tryptophan supplements were associated with alterations in the weighting of gains and small losses perhaps reflecting reduced loss-aversion, and a marked and significant diminution of the reflection effect. We conclude that serotonin activity plays a significant role in nonnormative risky decision-making under conditions of uncertainty.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18823228     DOI: 10.1162/jocn.2009.21122

Source DB:  PubMed          Journal:  J Cogn Neurosci        ISSN: 0898-929X            Impact factor:   3.225


  26 in total

1.  Risk-seeking for losses is associated with 5-HTTLPR, but not with transient changes in 5-HT levels.

Authors:  Philipp T Neukam; Nils B Kroemer; Yacila I Deza Araujo; Lydia Hellrung; Shakoor Pooseh; Marcella Rietschel; Stephanie H Witt; Uwe Schwarzenbolz; Thomas Henle; Michael N Smolka
Journal:  Psychopharmacology (Berl)       Date:  2018-05-05       Impact factor: 4.530

Review 2.  Serotonin and dopamine: unifying affective, activational, and decision functions.

Authors:  Roshan Cools; Kae Nakamura; Nathaniel D Daw
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

Review 3.  The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans.

Authors:  Robert D Rogers
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

4.  Epigenetics in Developmental Disorder: ADHD and Endophenotypes.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum
Journal:  J Genet Syndr Gene Ther       Date:  2011-06-30

5.  Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males.

Authors:  Philippa L Rock; Catherine J Harmer; Sarah F B McTavish; Guy M Goodwin; Robert D Rogers
Journal:  J Neurosci       Date:  2013-09-25       Impact factor: 6.167

6.  Dopamine modulates risk-taking as a function of baseline sensation-seeking trait.

Authors:  Agnes Norbury; Sanjay Manohar; Robert D Rogers; Masud Husain
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

7.  Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum; Mark Gold
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-30

8.  Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders.

Authors:  Gabriella Juhasz; Darragh Downey; Neal Hinvest; Emma Thomas; Diana Chase; Zoltan G Toth; Kathryn Lloyd-Williams; Krisztina Mekli; Hazel Platt; Antony Payton; Gyorgy Bagdy; Rebecca Elliott; J F William Deakin; Ian M Anderson
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

9.  Rapid decision-making under risk.

Authors:  Robert Adam; Paul M Bays; Masud Husain
Journal:  Cogn Neurosci       Date:  2011-10-12       Impact factor: 3.065

10.  Serotonin and dopamine play complementary roles in gambling to recover losses.

Authors:  Daniel Campbell-Meiklejohn; Judi Wakeley; Vanessa Herbert; Jennifer Cook; Paolo Scollo; Manaan Kar Ray; Sudhakar Selvaraj; Richard E Passingham; Phillip Cowen; Robert D Rogers
Journal:  Neuropsychopharmacology       Date:  2010-10-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.